ARTICLE | Company News
Galectin Therapeutics, SBH Sciences deal
February 3, 2014 8:00 AM UTC
Galectin and SBH formed a JV - Galectin Sciences LLC - to research and develop oral small molecule galectin-3 (LGALS3) inhibitors to treat organ fibrosis and cancer. The JV, which will have headquart...